Oxford Nanopore announces £100 million ($140M) fundraising from global investors
Nanopore sequencing the SARS-CoV-2 genome: introduction to protocol
Oxford Nanopore Technologies announces new collaboration with 10x Genomics to make single-cell and spatial full-length isoform transcript sequencing accessible to any laboratory
Products | Oxford Nanopore Technologies
Sequencing Unlimited
National German initiative partners with Oxford Nanopore to advance research of rare diseases with nanopore-based genome sequencing
Contact us | Oxford Nanopore Technologies
Products | Oxford Nanopore Technologies
Oxford Nanopore Technologies announces advanced development of LamPORE, for rapid, highly scalable, low-cost COVID-19 detection
Transforming complex immune disease through personalised medicine using nanopore technologies
NCM 2022: Using nanopore sequencing to investigate genome evolution in fungal symbioses: ploidy, repetitive elements, and reproduction
Oxford Nanopore Technologies · GitHub
Oxford Nanopore Technologies Company Profile: Stock Performance & Earnings | PitchBook
Scale-up: Oxford Nanopore's new high-tech factory comes online
Oxford Nanopore Technologies
Oxford Nanopore Technologies and Geneyx Announce the First Scalable Software Solution to Advance the Future Clinical Use of Nanopore Sequencing » Geneyx
Alexander Payne: Barcode-specific adaptive sampling — from human gene panels to viral amplicons - YouTube
Nanopore Live
Oxford Nanopore Technologies and Geneyx announce the first scalable software solution to advance the future clinical use of nanopore sequencing » Geneyx
Careers
Nanopore Community Meeting 2021: Day 3
Oxford Nanopore Technologies PLC | GB00BP6S8Z30 | 23783705 | UMushroom
Berenberg Bank Reiterates Oxford Nanopore Technologies (LON:ONT) Buy Recommendation
To enable the analysis of anything, by anyone, anywhere
Media resources and contacts
